Cortechs.ai | Automatic brain segmentation for all: the power of the Dynamic Atlas™

Automatic brain segmentation for all: the power of the Dynamic Atlas™

In 1996 FreeSurfer§, and later NeuroQuant® in 2006, revolutionized image segmentation by introducing software for the automation of processing and analyzing MRIs. The Bayesian approach used for this automatic image segmentation was based on a static atlas, which works very well for a large part of the population but shows limitations when the subject’s anatomy is too far from the generic norm or too far outside the standard cohort age range.

One June 1, 2015, Cortechs.ai released the patented Dynamic Atlas™ developed for NeuroQuant 2.0, which introduces a new unique, approach allowing automatic segmentation and volume measurements for patients ranging from 3-100 years, and furthering robustness of segmentation and goodness-of-fit across all age ranges to atlas.

Cortechs.ai | Automatic brain segmentation for all: the power of the Dynamic Atlas™

The Dynamic Atlas creates a personalized atlas instantaneously based on patient specific covariates and prior anatomical knowledge derived from a large database. The prior knowledge is represented by the target image, likelihoods, and class priors, which are compiled over a large cohort of individuals.

Using proprietary algorithms, the patients observed data, which is comprised of original image data and derived data from image registration and segmentation, is further processed to predict the atlas parameters for an individual. An individual’s atlas parameters then form the basis of the personalized atlas allowing for the segmentation of virtually any patient instantly.

Want to learn more about Cortechs.ai Dynamic Atlas? Cortechs.ai has developed a Dynamic Atlas white paper, which is now available for download.

 

[§] The FreeSurfer software application for cortical reconstruction and volumetric segmentation was originally developed by Anders M. Dale et al. at Massachusetts General Hospital/Harvard Medical School and is jointly owned by Cortechs.ai and Massachusetts General Hospital.

More Resources

11/04/2025

NeuroQuant Dementia in Different Use Cases 

NeuroQuant transforms brain imaging into a measurable biomarker for neurodegeneration by combining volumetric data with clinical expertise.

10/29/2025

Enhancing Brain Tumor Treatment with RT STRUCT Images: The Promise of Automation

Automating the generation of RT STRUCT images with NeuroQuant Brain Tumor can streamline workflows and elevate the standard of care

10/15/2025

Sharper Screening, Smarter Biopsies: OnQ Prostate and the Next Step in Imaging

Read to learn how OnQ Prostate goes beyond existing solutions like DynaCAD and redefines biopsy precision

10/14/2025

Cortechs.ai Acquires ZepMed to Expand AI-Powered Neuroimaging Capabilities

This strategic acquisition strengthens Cortechs.ai’s position at the forefront of radiological innovation and expands its suite of best-in-class solutions

10/07/2025

Cortechs.ai Expands Partnership with Strategic Radiology to Advance Imaging Innovation Across Private Practices

Cortechs.ai and Strategic Radiology have now broadened their alliance to include Cortechs.ai’s full suite of imaging solutions.

10/06/2025

Clinical Performance of NeuroQuant: Transforming Brain MRI Analysis

NeuroQuant has consistently demonstrated strong clinical performance across multiple conditions, including Alzheimer’s , epilepsy, TBI, and MS.
Scroll to Top